The protease inhibitors N-tosyl-L-phenylalanylchloromethyl ketone (TPCK) and N-tosyl-Llysylchloromethyl ketone (TLCK) have previously been shown to selectively inhibit growth of simian virus 40-transformed cells, suggesting that proteolytic enzymes play a role in loss of cellular growth control following viral transformation. In contrast, this study shows that TPCKmediated growth inhibition is non-selective, since the growth of both simian virus 40-transformed and untransformed 3T3 cells is similarly reduced by TPCK treatment. Under certain conditions, TPCK treatment of simian virus 40-transformed cells yields a reversible "growth plateau" condition which mimics, .but is not equivalent to, contact inhibition of growth. The growth inhibitory effects of TPCK are due to inhibition of protein synthesis, since TPCK treatment resulted in a diminution of protein synthesis and since the "growth plateau" effect was also observed in cultures treated with cycloheximide.
Untransformed fibroblasts in tissue culture show a characteristic reduction in the frequency of cell division upon formation of a confluent monolayer. This phenomenon has been termed contact inhibition or density-dependent inhibition of cell growth (1, 2) . In contrast, simian virus 40 (SV40)-transformed cells continue division beyond confluency and frequently exhibit multilayered cell growth.
Exposure of confluent, untransformed fibroblast monolayers to low concentrations of proteolytic enzymes can cause transient release from density-dependent inhibition of growth (3, 4) . Since proteolytic enzyme treatment can thus cause the growth characteristics of untransformed cells to resemble those of transformed cells, increased production or activity of proteolytic enzymes might be responsible for the loss of density-dependent growth control which characterizes cells transformed by oncogenic viruses. In support of this hypothesis, Bosmann (5, 6) found increased proteolytic activity in homogenates of 3T3 cells transformed by both DNA and RNA tumor viruses. Schnebli (7) reported an increase in "protease-like" activity in DNA virus-transformed cells, and Unkeless et al. (8) and Ossowski et al. (9) recently de- scribed an enhanced fibrinolytic activity in fibroblasts transformed by either oncogenic DNA or RNA viruses. This enhanced "Fibrinolysin T" activity in transformed cell cultures apparently results from increased production or activity of a Abbreviations: TPCK, N-tosyl-L-phenylalanylchloromethyl ketone; TLCK, N-tosyl--lysylchloromethyl ketone; SV40, simian virus 40; SV3T3, simian virus 40-transformed 3T3 cells; MEM X 4, Eagle's minimum essential medium containing a 4-fold concentration of vitamins and essential amino acids; FBS, fetal-bovine serum; PBS, phosphate-buffered saline; TCA, trichloroacetic acid. cellular proteolytic enzyme (10) which subsequently cleaves serum plasminogen to plasmin (11) , thus generating the fibrinolytic activity.
If proteolytic enzymes play an essential role in loss of density-dependent growth control in virus-transformed fibroblasts, then inhibition of cellular protease activity by appropriate protease inhibitors might be able to reverse the unrestrained growth of the transformed cells and cause them to reacquire density-dependent growth inhibition. Prival (12) found that the saturation density, but not the growth rate, of simian virus 40-transformed 3T3 (SV3T3) cells was reduced by treatment of cells with the chymotrypsin inhibitor, IVtosyl-L-phenylalanylchloromethyl ketone (TPCK). Goetz et at. (13) showed that the trypsin inhibitor, N-tosyl-i- [5] [6] [7] [8] [9] [10] min, and counted in a hemocytometer.
To measure protein synthesis, a 'H-labeled -amino-acid mixture (New England Nuclear Corp.) in PBS (500,gCi/ml) was added to cell cultures at 2.5 pCi/ml of medium. One hour after isotope addition, the medium was decanted and the cells were washed three times with PBS, extracted three times with 5 ml of cold 5% trichloroacetic acid (TCA), and then the cell monolayer was dissolved in 1 ml of 0.5 N NaOH. Aliquots of the sample were neutralized with 4 N HC1, precipitated with 5% TCA, and heated at 90°in a water bath for 30 min. The hot TCA precipitable materials were collected on glass-fiber filter discs (Whatman, GF/C), dried, and counted in 10 ml of toluene scintillation fluid. The radioactivity of all TCA washes was determined by counting aliquots of the TCA extracts in 10 ml of Bray's scintillation fluid (17) .
For quantitative incorporation measurements, ['H]thymidine (New England Nuclear Corp., specific activity 20 Ci/mM) in PBS (100 pCi/ml) was added to the plates at a final concentration of 5 uCi/ml for 1 hr. The medium was then decanted, the cells were washed twice with 5 ml of cold Dulbecco's Tris buffer (pH 7.4) (18), extracted three times with 5 ml of cold 5% TCA, washed five times with cold 95% ethanol, and, finally, dissolved in 1 ml of 0.5 N NaOH. Aliquots of NaOH-dissolved samples were precipitated with cold 5% TCA and counted as described above. For autoradiography, the cells were labeled with 5 uCi/ml of ['H Ithymidine for 4 hr and processed as described previously (19) . The cell lines were shown to be free from mycoplasma contamination by periodic assay of the cells using the same autoradiographic procedure (19 Fig. 1A and B). The overall effect of TPCK on the growth of both cell lines is strikingly dependent upon the TPCK concentration. Thus, 50 ,ug/ml of TPCK (not shown) has no effect on the growth rate of SV3T3 cells, 100 ,g/ml of TPCK decreases the growth rate of SV3T3 cells without changing the final cell density, and 200 ,g/ml of TPCK causes SV3T3 cells to achieve a "growth plateau" at 4 X 105 cells per plate (Fig. IA) .
TPCK produced similar effects on the growth of untransformed 3T3 cells, in that 50 ,g/ml reduced the growth rate, 100 ,g/ml produced a "growth plateau" at ,Pg/ml; * -, 200 pg/ml. (The numbers on the ordinate have been multiplied by 10-6.) to growth inhibition by TPCK than are their transformed SV3T3 counterparts. The cell density at the time TPCK is added also influences the final cell density to which the cells grow. This is illustrated by Fig. 2, which shows (20, 21) . We therefore determined whether TPCK caused inhibition of protein synthesis that the cycloheximide-induced "growth plateau" is reversible, following removal of the cycloheximide-containing medium, even after 6 days of cycloheximide treatment. In addition, cultures treated with 0.5 gg/ml of cycloheximide show a 95% inhibition of protein synthesis as compared with untreated control cultures.
TPCK-Induced Growth Plateau. The data in Figs. 1 and 2 show that appropriate TPCK concentrations cause a "growth plateau" condition in which there is no net increase in the number of SV3T3 cells on the petri dish. There is, however, an increase in the total number of cells in the culture, since an appreciable number of dead cells appear in the medium each day during the "growth plateau" condition (Fig. 2) . The "growth plateau" condition is not due to simple toxicity, since almost all the cells which remain on the petri dish after 4-6 days of TPCK treatment are able to divide if the TPCK is removed (Figs. 1A and 2 ). Since TPCK-treated SV3T3 cells at a plateau cell density of 1.5 X 106 cells per dish do not show extensive cell-to-cell contact and have not formed a confluent monolayer, the "growth plateau" condition does not correspond to a reacquisition of contact inhibition. Achievement of "growth plateaus" at the very low cell concentrations of 4 X 105 SV3T3 cells per dish and 2 X 105 3T3 cells per dish reinforces this conclusion. DISCUSSION Our results show that the overall effect of TPCK treatment on cell growth depends upon the cell density at the time of TPCK treatment, as well as the TPCK concentration. Cultures treated with TPCK at low initial cell densities show a more rapid inhibition of cell multiplication and a lower growth plateau cell density than those treated at higher initial cell densities ( Figs. 1 and 2) . Thus, meaningful comparison of the effects of TPCK treatment on different cell lines requires that the cells be treated with TPCK at approximately the same initial cell density.
When 3T3 and SV3T3 cells were seeded at the same initial cell density and treated with TPCK 24 hr later, a similar pattern of growth inhibition was observed with both cell lines. Concentrations of TPCK which are required to reduce the growth rate of SV3T3 cells are even more inhibitory to the growth of untransformed 3T3 cells (Fig. 1) . Thus, 200 ,g/ml of TPCK yields a "growth plateau" with SV3T3 cells, while 100 ug/ml is sufficient to cause a "growth plateau" in 3T3 cultures. The essential point is that we observed no selective effect of TPCK on the growth of the virus-transformed 3T3 cells as compared with untransformed 3T3 cells. Our results thus differ from those of Schnebli and Burger (14) who reported a selective reduction in the growth rate of SV3T3 cells treated with 10,ug/ml of TPCK. Differences in cell lines and in the manner in which TPCK-containing media were prepared might account for some of the differences in our results. However, we also observed no reduction of the growth rate of our SV3T3 cells when they were treated with TPCK dissolved in dimethylsulfoxide at concentrations up to 25 Ag/ ml. At a minimum, our results show that increased sensitivity to TPCK is not an invariable consequence of transformation by SV40.
In our experiments, concentrations of TPCK which are required to reduce the growth of SV3T3 cells also depress through its effect on protein synthesis, since the dose-response curve of growth inhibition in TPCK-treated cultures is exactly reproduced in cultures treated with cycloheximide, a known inhibitor of protein synthesis. The mechanism by which TPCK inhibits protein synthesis in mammalian cells is not known; it may inactivate one of the peptide chain elongation factors in protein synthesis as it does in bacteria (24, 25) , and (or) it may act by inhibiting cellular RNA synthesis (26) which is required for protein synthesis. Whatever the mechanism, the growth inhibitory effects of TPCK can no longer simply be ascribed to inhibition of proteolytic activity.
Treatment with 200 ug/ml of TPCK can cause SV3T3 cells to stop increasing in net cell number at cell densities which approximate the low saturation density of untransformed 3T3 cells. However, this "growth plateau" phenomenon is not equivalent to reacquisition of contact-inhibition of cell division because (a) TPCK-treated SV3T3 cells at 1.5 X 106 cells per dish do not show extensive cell-to-cell contacts, (b) there is no marked decrease in DNA synthesis in cells on such a TPCK-induced "growth plateau'" as there is in contactinhibited untransformed cell monolayers, and (c) the final "growth plateau" cell density depends upon the cell density at which the cells are treated with TPCK. The TPCK-induced "growth plateau" appears to be the net result of approximately equal rates of cell multiplication and cell detachment from the monolayer. Thus, low "saturation" density in TPCK-treated cultures cannot be used as the sole criterion for reacquisition of contact-inhibition of cell growth.
Although we have not investigated growth inhibition by TLCK in detail, we have previously reported (22) (14) . In addition, TLCK has been shown to inhibit protein synthesis in poliovirusinfected HeLa cells (21) and RNA synthesis in lymphocytes (26) in the concentration range (1 X 10-4 M) previously reported (14) to selectively inhibit the growth of SV40-transformed cells. Thus, TLCK may also cause growth inhibition via inhibition of macromolecular synthesis rather than by inhibiting cellular proteases.
Our results with TPCK illustrate the many difficulties involved in using protease inhibitors like TPCK and TLCK in cell cultures to investigate the role of proteolytic enzymes in virus-induced cell transformation. Protease inhibitors without adverse side effects on cell metabolism and which are stable under cell culture conditions are required if this approtein synthesis. We suggest that TPCK affects cell growth Proc. Nat. Acad. Sci. USA 71 (1974) proach is to be fruitful.
